Supply and delivery of solid dosage forms (tablets/capsules) to the national department of health until 30 april 2029

This annexure (Annexure A) provides the returnable documents schedule for the tender HP09-2026SD/01 for the supply and delivery of solid dosage forms to the Department of Health for the period ending 30 April 2029. It lists all required documents in submission order with admin codes, document names, and mandatory/administrative status. Bidders must submit documents in the exact order, with each document as a separate file on the USB drive named using the admin code abbreviations. Where a document is not applicable, bidders must indicate "N/A" with justification. The schedule covers administrative documents, mandatory eligibility and compliance documents, licensing and registration requirements specific to pharmaceutical products (SAHPRA licences, MRCs, GMP), pricing submission, and contract condition acknowledgements.

Submission format: All bid documents must be sorted, filed, and submitted in the exact order listed in the returnable documents schedule (Annexure A). Each compilation sequence (document) must be saved as a separate file on the USB flash drive, using the admin code abbreviations in the file name. A digital copy of the completed bid on a USB flash drive (Set 2 & 3) is required. The signed Excel Bid Response (Pricing Schedule) must be signed in the space provided; if not signed, the bid will not be considered for evaluation. Where a specific document is not applicable, the bidder must explicitly indicate "N/A" and provide a justification for its exclusion. If a section is blacked out in the "N/A" field, it is not a valid selection option.

Returnable forms and documents (mandatory unless marked administrative or conditional):

• Covering Letter (CL) — Administrative
• Bid/File Index (BFI) — Administrative
• PBD3: Bid Signature Authorisation (original or certified copy) — Mandatory
• SBD 1: Invitation to Bid — Mandatory for bidding entity
• PBD 4.1: Contact Details of Bidder — Administrative
• CSD Registration report — Mandatory
• SARS Tax Clearance Pin — Mandatory
• CIPC registration certificate — Mandatory
• CIPC notice of change in Directors — Administrative
• Proof of company ceding, mergers, acquisition, and name changes — Administrative
• PBD 9.1: Entity Directors — Administrative, if single bidding entity
• PBD 9.2: Multi-entity Bid — Administrative, if multi bidding entity
• Identification documents of Directors (certified copies) — Administrative
• SBD 4: Declaration of Interest — Mandatory for bidding entity
• SBD 6.1: Preference Points Claim — Mandatory
• Valid B-BBEE Certificate (SANAS accredited) — Mandatory, where applicable
• Sworn Affidavit - EME — Mandatory, where applicable
• Sworn Affidavit - QSE — Mandatory, where applicable
• Multi-entity Bids: Certified copy of relevant agreement between entities including all other mandatory documents as specified in Section 7.13 — Mandatory
• PBD 11: Declaration of Financial Solvency and Business Rescue Status — Mandatory
• PBD5: Good Manufacturing Practice (GMP) Declaration of Compliance — Mandatory (authorised signatory per PBD 3 to sign)
• SBD5: National Industrial Participation Programme — Mandatory for bidding entity
• Valid licence to manufacture or import (LICMI) with annexures (certified copies) — Mandatory
• Valid licence to manufacture or import for local manufacturing sites on MRC (LICM) with annexures (certified copies) — Mandatory, preference for locally produced products
• Valid licence to manufacture/import/distribute/wholesale Complementary Medicines (LICCM) with annexures and DA02 product list (certified copies) — Mandatory
• Valid licence to manufacture/import/distribute/wholesale medical device or IVD (LICMD) with annexures (certified copies) — Mandatory
• Valid Medicine Registration Certificates (MRC) marked with relevant item number, sorted and filed in numerical order (certified copies) — Mandatory
• MRC Annexures as issued by SAHPRA (certified copy) — Administrative
• Valid Variation Summary for any changes on MRC per SAHPRA BAU Variations Communication (certified copies) — Administrative
• PBD1: Third Party Authorisation Declaration — Administrative
• PBD 1.1: List of products offered sourced from third party — Administrative
• PBD 1.2: Unconditional written undertaking from third party or formal letter — Administrative
• Original Package Insert (PI) or QR code with professional information approved by MCC/SAHPRA for each product offered — Administrative
• Proof of sample submission — Administrative
• Bidder's item list (list of products offered) — Administrative
• PBD 8: SRCC and GCC Declaration of Compliance — Mandatory for bidding entity (authorised signatory per PBD 3 to sign)
• SRCC: Copy of Special Requirements and Conditions of Contract — initial every page — Mandatory
• GCC: Copy of General Conditions of Contract — initial every page — Mandatory
• Signed Excel Bid Response (Pricing Schedule) — Mandatory
• USB Flash Drive with digital copy of completed bid — Administrative

The document provided (Annexure A) lists mandatory eligibility documents and administrative requirements but does not specify the evaluation methodology, scoring split (e.g., 80/20 or 90/10 preference points), minimum qualifying thresholds for functionality/technical evaluation, or the stages of evaluation. Bidders must refer to the main tender document for the evaluation criteria, preference point system, and any minimum scores required.

Scope: Supply and delivery of solid dosage forms to the Department of Health for the period ending 30 April 2029. Bidders must hold valid Medicine Registration Certificates (MRC) for each product offered, with MRCs marked by the relevant item number and sorted/filed in numerical order. Valid licences to manufacture or import (including annexures) are required for the bidding entity (LICMI) and for local manufacturing sites listed on the MRC (LICM), with preference for locally produced products. Valid licences for Complementary Medicines (LICCM) and medical devices/IVDs (LICMD) are required where applicable. Original Package Inserts (PI) or QR codes with professional information approved by MCC/SAHPRA must be submitted for each product offered. Good Manufacturing Practice (GMP) compliance declaration (PBD5) is mandatory. Proof of sample submission and a bidder's item list of products offered are required administratively. Variation Summaries for any MRC changes per SAHPRA BAU Variations Communication must be provided where applicable.

Pricing must be submitted on the signed Excel Bid Response (Pricing Schedule). The schedule must be signed in the space provided; unsigned schedules will result in the bid not being considered for evaluation. No further details on pricing format (firm/non-firm), bonds, guarantees, payment terms, or financial capacity thresholds are provided in this annexure.

Mandatory compliance documents:

• CSD Registration report
• SARS Tax Clearance Pin
• CIPC registration certificate
• PBD3: Bid Signature Authorisation (original or certified copy)
• SBD 1: Invitation to Bid
• SBD 4: Declaration of Interest
• SBD 6.1: Preference Points Claim
• PBD 11: Declaration of Financial Solvency and Business Rescue Status
• PBD5: GMP Declaration of Compliance (signed by authorised signatory per PBD 3)
• SBD5: National Industrial Participation Programme
• Valid licence to manufacture or import (LICMI) with annexures (certified copies)
• Valid Medicine Registration Certificates (MRC) with annexures (certified copies, marked and sorted)
• PBD 8: SRCC and GCC Declaration of Compliance (signed by authorised signatory per PBD 3)
• SRCC: initial every page
• GCC: initial every page
• Signed Excel Bid Response (Pricing Schedule)

Conditional B-BBEE requirements:

• Valid B-BBEE Certificate (SANAS accredited) — mandatory where applicable
• Sworn Affidavit - EME — mandatory where applicable
• Sworn Affidavit - QSE — mandatory where applicable

Multi-entity bids (partnerships, joint ventures, consortiums) require a certified copy of the relevant agreement between entities and all mandatory documents for each entity as specified in Section 7.13.

Preference for locally produced products is indicated for LICM (local manufacturing sites).

Administrative documents (required unless not applicable, then justify with "N/A"): CIPC notice of change in Directors, proof of company changes, PBD 9.1/9.2, director IDs, MRC annexures, variation summaries, third-party authorisations (PBD1, 1.1, 1.2), package inserts, proof of samples, bidder's item list, USB digital copy.

{"closingDate":"30 APRIL 2029"}

{"name":null,"email":null,"phone":null,"department":"OF HEALTH FOR THE PERIOD ENDING 30 APRIL 2029","address":"butor name Name of authorised distributor"}

No eligibility criteria specified

Invoice line information requirements:

• Item Barcode: EAN 13 barcode as it appears on a single sales unit.
• Generic Product Description: As per Contract Circular and Purchase Order.
• Brand Name: As per Contract Circular and Purchase Order.
• Contract Reference: Contract number, addenda (two placeholders), and item number (three placeholders) as per Contract Circular; item number must correspond with Generic Product Description.
• Quantity Ordered: Original requested quantity as per Purchase Order.
• Quantity Supplied: Quantity of product delivered on this invoice.
• Batch Number: Each batch must appear on a separate line with the appropriate quantity.
• Expiry Date: Each expiry date must appear on a separate line with the appropriate quantity.
• Unit Price (VAT inclusive): As per Contract Circular or addendum, includes VAT and delivery, to four decimal points.
• Total: Unit Price multiplied by delivered quantity.

Summary invoice totals:

• Total Ex VAT: To two decimal points.
• VAT Amount: To two decimal points.
• Total (Ex VAT + VAT): To two decimal points.

Proof of Delivery requirements:

• Date goods received.
• Printed name and PERSAL number of person receiving and signing.
• Signature of receiver.
• Number of cartons received.
• Facility stamp space (must not obscure invoice detail).
• GRV number space.
• Claim Reference Number if relevant.

Invoice pricing and totals:

• Unit Price must be VAT inclusive, include delivery, and be stated to four decimal points as per Contract Circular or addendum.
• Line Total = Unit Price × Quantity Supplied.
• Invoice summary must show Total Ex VAT, VAT Amount, and Total (Ex VAT + VAT), each to two decimal points.
• Invoice header must be one of: TAX INVOICE (original), COPY TAX INVOICE (Supplier Copy), or COPY TAX INVOICE (Customer Copy).
• Purchase Order Number and barcode (1D symbology) must appear on each invoice; only one Purchase Order per invoice.
• Supplier must provide VAT registration number, Company Registration number, and CSD registration number (MAAA).
• Pay office (Invoice To) details: name, address, VAT number, and phone as per Purchase Order.

Mandatory invoice data fields for contract compliance:

• Supplier information (not distributor): logo, name (as per contract), NDoH Supplier Code (per contract circular), CSD registration number (MAAA), Company Registration number, VAT number, authorised distributor name.
• Supplier contact information: physical and postal address, queries contact number and email, debtors contact number and email.
• 'Deliver To' information: Supplier account number, Facility Name, Demander code, MHFL code, delivery address, name/rank of person delegated to receive delivery, facility phone — all as per Purchase Order.
• Invoice details: unique invoice number, 1D barcode of invoice number, invoice date, page numbering.
• Order details: Purchase Order number and barcode, order captured date, special instructions as per Purchase Order.
• Goods Received By (Proof of Delivery): date received, printed name, PERSAL number, signature, number of cartons, facility stamp space, GRV number, claim reference number if relevant.
• All fields are mandatory on every invoice for products delivered under this contract.

Contractual invoice and delivery documentation requirements:

Invoice header: Must be one of TAX INVOICE (original), COPY TAX INVOICE (Supplier Copy), or COPY TAX INVOICE (Customer Copy).

Supplier information (not distributor): logo, name as per contract, NDoH Supplier Code per contract circular, CSD registration number (MAAA), Company Registration number, VAT number, authorised distributor name.

Supplier contact information: physical address, postal address, queries phone and email, debtors phone and email.

Deliver To information (per Purchase Order): Supplier account number, Facility Name, Demander code, MHFL code, delivery address, name/rank of person delegated to receive delivery, facility phone.

Invoice details: unique invoice number, 1D barcode of invoice number, invoice date, page numbering.

Order details (per Purchase Order): Purchase Order number and 1D barcode, order captured date, special instructions.

Invoice line information: EAN 13 item barcode, generic product description, brand name, contract reference (contract number, addenda two placeholders, item number three placeholders), quantity ordered, quantity supplied, batch number (separate line per batch), expiry date (separate line per expiry), unit price VAT inclusive to four decimals (includes delivery), line total.

Summary totals: Total Ex VAT (two decimals), VAT amount (two decimals), Total (two decimals).

Invoice To (Pay office) information: name, address, VAT number, phone — all per Purchase Order.

Goods Received By (Proof of Delivery): date received, printed name, PERSAL number, signature, number of cartons, facility stamp space (must not obscure detail), GRV number, claim reference number if relevant.

All listed fields are mandatory on every invoice for products delivered under this contract.

Supply and Delivery of Solid Dosage Forms to the Department of Health for the period ending 30 April 2029.

Closing date: 28 September 2026 at 11:00 am. Non-compulsory online briefing session via MS Teams on 18 September 2026 at 10H00 (link: https://teams.microsoft.com/meet/31443612280593?p=CVfQjt78m3LX5KlBTX). Bid document available from 28 August 2026.

Non-compulsory online briefing session via MS Teams on 18 September 2026 at 10H00. Link: https://teams.microsoft.com/meet/31443612280593?p=CVfQjt78m3LX5KlBTX.

Enquiries: [email protected]. Office hours: 07h30–15h30. Delivery address: DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143.

Bids must be delivered to DR AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, PRETORIA, 0143 by the closing date and time. The bid document is obtainable from the Department of Health website (www.health.gov.za) and the National Treasury e-tender portal from 28 August 2026. All enquiries must be emailed to [email protected] during office hours (07h30–15h30).

Four-phase evaluation: Phase I – Compliance with mandatory administrative bid requirements; Phase II – Compliance with product, technical and legal mandatory requirements; Phase III – B-BBEE compliance per Section 9 of the Special Requirements and Conditions of Contract (SRCC); Phase IV – Recommendation and award.

Supply and delivery of solid dosage forms to the Department of Health for the period ending 30 April 2029. Detailed product, technical and legal specifications are contained in the full bid document.

Bidders must be registered on the Central Supplier Database (CSD) and have a valid SARS tax compliance status (tax pin). B-BBEE compliance will be evaluated per Section 9 of the Special Requirements and Conditions of Contract. Standard returnable forms (SBD 1, SBD 4, SBD 6.1, SBD 8, SBD 9, and Authority to Sign/Board Resolution) are required; all must be completed, signed and submitted with the bid.

Four-phase evaluation: Phase I – Compliance with mandatory administrative bid requirements; Phase II – Compliance with product, technical and legal mandatory requirements; Phase III – B-BBEE compliance per Section 9 of the Special Requirements and Conditions of Contract; Phase IV – Recommendation and award.

Bidders must provide details of all directors for each entity in the bidding enterprise, including full names, surname, entity designation (A, B or C), nationality, identity number or passport number (for foreigners), director appointment status (Y/N), executive or non-executive classification, and any other directorships or ownership in other enterprises (Y/N with specification if yes).

Each entity in a multi-entity bidding enterprise must be registered on the Central Supplier Database (CSD) with a valid MAAA number. Directors must be formally appointed and their details disclosed as specified.

Bidders must provide details of all directors for each entity in the bidding enterprise, including full names, surname, entity designation (A, B or C), nationality, identity number or passport number (for foreigners), director appointment status (Y/N), executive or non-executive classification, and any other directorships or ownership in other enterprises (Y/N with specification if yes).

Multi-entity bidding enterprises must categorise their structure as one of: Partnership, Joint Venture Unincorporated, Consortium, or Listed Company. Each entity must have a valid CSD registration (MAAA number).

This document is the PBD 4.1 Contact Details form for tender HP09-2026SD/01 (Supply and Delivery of Solid Dosage Forms to the Department of Health). It requires bidders to provide comprehensive contact information for contract management, order enquiries, and national key account/tender management purposes. The form captures the bidder's legal name, CSD number, vendor number, and multiple contact points with titles, names, emails, and phone numbers.

Bidders must complete and submit the PBD 4.1 Contact Details form with the following information:

• Registered legal name of bidder as on CSD
• Central Supplier Database (CSD) number
• Vendor number
• SBD 1 reference
• Postal address for contract enquiries (to be printed on contract cover page)
• Contract enquiries contact: title, surname, email, office telephone, cell number, other contact number
• Contact regarding orders enquiries: name and surname, email, telephone number
• National Key Account Manager or Tender Manager: name and surname, email, office telephone, cell number

Bidders must be registered on the Central Supplier Database (CSD) and provide their CSD number and vendor number. No further eligibility criteria are specified in the provided document.

Cell Q1: PBD 4.1 National Key Account Manager or Tender Manager (or Tender Manager)

{"name":null,"email":null,"phone":null,"department":null,"address":"or member."}

Preference points for specific goals are claimed through a valid B-BBEE sworn affidavit (EME/QSE) or SANAS-accredited B-BBEE certificate. An incorrectly completed affidavit is deemed invalid and no preference points will be allocated. Enterprises with annual turnover exceeding R50 million must submit a SANAS-accredited B-BBEE certificate and do not qualify for an EME/QSE affidavit.

B-BBEE compliance for preference points:

• EME: annual turnover ≤ R10 million – submit a sworn affidavit.
• QSE: annual turnover between R10 million and R50 million – submit a sworn affidavit.
• Turnover > R50 million: submit a valid SANAS-accredited B-BBEE certificate (EME/QSE affidavit not accepted).

Sworn affidavit must include:

1. Deponent’s full name and ID number as per identity document.
2. Designation (director, owner or member) confirming authorisation.
3. Enterprise name as per CIPC registration and business address.
4. Percentages of black ownership, black female ownership and designated group ownership.
5. Total revenue for the year under review and whether based on audited financial statements or management accounts.
6. Financial year end per enterprise registration documents.
7. Single B-BBEE Status Level of Contributor.
8. Empowering supplier status (QSEs must select the basis).
9. Deponent signature date and Commissioner of Oaths signature date must match.
10. Commissioner of Oaths must not be an employee or ex officio of the enterprise.

CSD registration and valid SARS tax compliance status (tax pin) are required per the main tender.

B-BBEE compliance for preference points:

• EME: annual turnover ≤ R10 million – submit a sworn affidavit.
• QSE: annual turnover between R10 million and R50 million – submit a sworn affidavit.
• Turnover > R50 million: submit a valid SANAS-accredited B-BBEE certificate (EME/QSE affidavit not accepted).

Sworn affidavit must include:

1. Deponent’s full name and ID number as per identity document.
2. Designation (director, owner or member) confirming authorisation.
3. Enterprise name as per CIPC registration and business address.
4. Percentages of black ownership, black female ownership and designated group ownership.
5. Total revenue for the year under review and whether based on audited financial statements or management accounts.
6. Financial year end per enterprise registration documents.
7. Single B-BBEE Status Level of Contributor.
8. Empowering supplier status (QSEs must select the basis).
9. Deponent signature date and Commissioner of Oaths signature date must match.
10. Commissioner of Oaths must not be an employee or ex officio of the enterprise.

Guidance issued under the Preferential Procurement Regulations, 2022.

Preference points for specific goals are claimed through a valid B-BBEE sworn affidavit (EME/QSE) or SANAS-accredited B-BBEE certificate. An incorrectly completed affidavit is deemed invalid and no preference points will be allocated. Enterprises with annual turnover exceeding R50 million must submit a SANAS-accredited B-BBEE certificate and do not qualify for an EME/QSE affidavit.

The tender HP09-2026SD/01 is for the supply and delivery of solid dosage forms (tablets and capsules) to the Department of Health for the period ending 30 April 2029. It comprises 59 distinct pharmaceutical items across multiple therapeutic classes, each specified by active ingredient, strength, dosage form, and pack size. Estimated quantities for the full tender period are provided per item. Bidders must offer products conforming to specifications, with valid registration and manufacturing licences, and provide full supply chain details including API sources, manufacturing sites, distributors, barcoding, and cost breakdowns.

Closing date: 28 September 2026 at 11:00 (as per tender record). No other dates (briefings, site visits, clarification deadlines) are stated in the provided document.

Submission must be made using the Excel bid response workbook (HP09-2026SD_01_Final BidResp_28 August 2026.xlsx). Bidders must complete all required fields for each item offered, including: registered legal name of bidder, Central Supplier Database (CSD) number, delivered price in ZAR (two decimals, not exceeding the current Single Exit Price (SEP) for the corresponding unit), delivered price per shipper pack (two decimals), SEP (current list - corresponding unit), registered product name, conformance to specification (Y/N) with deviation details if non-conforming, product registration number, licence to manufacture medicines (licence number and expiry date), pack sizes offered (unit pack, shelf pack), standard units in shipper pack, lead time (≤14 calendar days), initial lead time (≤75 calendar days), minimum order quantity, batch size in number of packs, monthly batch capacity in number of batches, technical amendment requirement (Y/N) with details if yes, EAN 13 barcode for unit and shelf packs, ITF14 barcode for shipper pack, 2D barcode or similar, NAPPI code, primary and secondary distributor names and addresses, primary, secondary and tertiary manufacturers as listed on the Medicine Register (MRC), indication if any listed manufacturers are third parties to the bidder (Y/N) with PBD1 completion if yes, API source details (up to three sources: full site name, address, country, contact), and cost breakdown percentages for API (local/imported), formulation (local/imported), packaging (local/imported), logistics, gross margin, and currency. All fields must be completed accurately; incomplete or non-compliant submissions may be disqualified.

Supply and delivery of solid dosage forms (tablets, capsules) to the Department of Health for the period ending 30 April 2029. The tender covers 59 items across multiple therapeutic classes (Procurement Class 2, Classes 34, 35, 36, 37). Each item is defined by active ingredient, strength, dosage form, and pack size (e.g., Acetazolamide 250mg tablet in packs of 100 and 28/30 tablets; Carbidopa 25mg/Levodopa 250mg tablet in packs of 100; Dapagliflozin 5mg and 10mg tablets in packs of 30; Empagliflozin 10mg and 25mg tablets in packs of 30; Sitagliptin 25mg, 50mg, 100mg tablets in packs of 30; Saxagliptin 2.5mg and 5mg tablets in packs of 30; Retinol (Vitamin A) 50,000 IU, 100,000 IU, 200,000 IU soft gel capsules in packs of 50). Unit of measure for pricing is per pack (unit pack or shipper pack as specified). Estimated quantities for the full tender period are provided per item (e.g., 86,060 packs for Acetazolamide 250mg 100-tablet pack; 2,600,076 packs for Thiamine 100mg 28/30-tablet pack). Products must conform to the stated specifications; deviations must be declared. Product registration number and valid licence to manufacture medicines are required. Barcoding requirements: EAN 13 for unit and shelf packs, ITF14 for shipper packs, 2D barcode or similar. NAPPI code must be provided. Manufacturer(s) must be listed on the Medicine Register (MRC). API sources (up to three) must be disclosed with full site details.

Pricing: Delivered price in ZAR per unit pack (two decimals) and per shipper pack (two decimals). Price may not exceed the current Single Exit Price (SEP) for the corresponding unit. Currency options: ZAR, USD, GBP, EUR, DKK, CHF, AUD, INR, Yuan, Other. Cost breakdown required as percentage of delivered price attributable to: API (local and imported), formulation (local and imported), packaging (local and imported), logistics, and gross margin. No information on bonds, guarantees, payment terms, or financial capacity thresholds is present in the document.

Bidders must be registered on the Central Supplier Database (CSD) and provide CSD number. Valid product registration number for each item offered. Valid licence to manufacture medicines (licence number and expiry date). Manufacturer(s) must be listed on the Medicine Register (MRC). API sources must be disclosed. Conformance to specification must be declared (Y/N) with deviations detailed. Barcoding compliance: EAN 13 for unit and shelf packs, ITF14 for shipper packs, 2D barcode or similar. NAPPI code required. Distributor details (primary and secondary) must be provided. If any manufacturer is a third party to the bidder, PBD1 must be completed. Lead time commitments: ≤14 calendar days (standard), ≤75 calendar days (initial). Monthly batch capacity and batch size must be declared. No explicit B-BBEE, CIDB, or local content percentage requirements are stated in the document.

Supply and delivery of solid dosage forms to the National Department of Health for the period ending 30 April 2029. The tender is subject to the National Industrial Participation (NIP) Programme where imported content equals or exceeds US$10 million (or R10 million for reporting). NIP obligation is 30% of imported content, discharged over seven years via investments, joint ventures, sub-contracting, licensee production, export promotion, sourcing arrangements or R&D. Successful bidders with contracts exceeding R10 million must report contract details to the DTI within 5 working days of award. Products must comply with the Medicines and Related Substances Act and GMP. Third-party sourcing requires an unconditional written undertaking from the manufacturer.

Closing date: 28 September 2026

Closing time: 11:00

Non-compulsory online briefing session: 18 September 2026 at 10:00 via MS Teams

Bid validity period: 180 days from closing date

SCM / bidding process enquiries: [email protected]

Technical enquiries: [email protected] (same address)

Physical submission address: Pharmaceutical Tender Box, Reception Area, National Department of Health, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria 0187

Postal address for DTI NIP reporting (post-award): Department of Trade and Industry, Private Bag X84, Pretoria 0001, attention Mr Elias Malapane

NIP programme contacts: Ms R Muthan, tel (012) 394 1288, mobile (066) 301 2051, email [email protected]

Submission method: Physical delivery to the Pharmaceutical Tender Box at the National Department of Health, Dr AB Xuma Building, 1112 Voortrekker Road, Pretoria Townlands 351-JR, Pretoria 0187. Bids must be deposited before the closing date and time. Late bids will not be accepted.

Returnable forms and documents (all must be completed, signed and submitted with the bid):

• SBD 1 (Invitation to Bid): Part A and Part B, signed as the offer cover page.
• PBD 3 (Bid Signature Authorisation) for single bidding enterprises, or PBD 3.1 for multi-entity enterprises (JV, consortium, partnership).
• PBD 4.1 (Supplier Details): completed electronically.
• PBD 9.1 (Directors Profile) for single entities, or PBD 9.2 for multi-entity enterprises.
• Bidder's Disclosure (SBD 4 equivalent): declares interest, state employment, and independent bid determination.
• SBD 6.1 (Preference Points Claim Form): claims B-BBEE points under the 90/10 system.
• Sworn Affidavit – B-BBEE (EME or QSE as applicable): valid SANAS-accredited B-BBEE certificate or sworn affidavit.
• PBD 8 (Declaration of Compliance with SRCC and GCC): signed by authorised signatory.
• PBD 11 (Declaration of Financial Solvency and Business Rescue Status): confirms solvency and no insolvency proceedings.
• PBD 5 (Declaration of Compliance with GMP): signed by authorised signatory confirming GMP compliance and no outstanding legal matters.
• SBD 5 (National Industrial Participation Programme): signed and submitted with the bid; triggers NIP obligations if imported content exceeds US$10 million.
• PBD 1 (Authorisation Declaration): required if sourcing products from a third party, with PBD 1.1 and third-party undertaking (PBD 1.2).

Disqualification risks: Any returnable form left unsigned or omitted; bids received after closing time; failure to provide tax compliance status (TCS PIN or CSD number); false declarations on any form.

Preference point system: 90/10 (Price 90 points, Specific Goals 10 points).

Specific Goals: B-BBEE Status Level of Contributor. Points allocated as follows: Level 1 = 10, Level 2 = 9, Level 3 = 8, Level 4 = 6, Level 5 = 5, Level 6 = 4, Level 7 = 3, Level 8 = 2, Non-compliant = 0.

Price points formula: Ps = 90

• (1 - (Pt - Pmin) / Pmin) where Pt is the tender price and Pmin the lowest acceptable price.

B-BBEE evidence required: Valid SANAS-accredited B-BBEE certificate or sworn affidavit (EME/QSE). Failure to submit valid evidence does not render the bid non-responsive but results in zero preference points for specific goals.

No minimum functionality or qualifying score is stated in the extracted text. Evaluation details beyond price and B-BBEE are not provided in the source material.

Supply and delivery of solid dosage forms (pharmaceutical tablets/capsules) to the National Department of Health for the period ending 30 April 2029.

Products must comply with the Medicines and Related Substances Act (as amended) and Good Manufacturing Practice (GMP) requirements. Bidders must declare GMP compliance via PBD 5.

If products are sourced from a third party, the bidder must provide an unconditional written undertaking from the third-party manufacturer (PBD 1.2) confirming supply for the contract duration.

National Industrial Participation (NIP) obligations apply if the contract has imported content equal to or exceeding US$10 million (or R10 million for reporting). NIP obligation is 30% of imported content, to be discharged over seven years through investments, joint ventures, sub-contracting, licensee production, export promotion, sourcing arrangements or R&D. Successful bidders with contracts exceeding R10 million must report contract details to the DTI within 5 working days of award.

No detailed product list, quantities, dosage strengths, packaging specifications, or delivery schedule are present in the extracted text.

Pricing: Not specified in the extracted text (no pricing schedule, bill of quantities, or pricing formula beyond the 90/10 preference points formula).

Performance guarantee: Required by the DTI as part of the NIP obligation process (submitted after NIP obligation agreement is signed).

Bid validity: 180 days.

Financial solvency declaration (PBD 11): Bidder must declare it is financially solvent, not under business rescue, liquidation, sequestration, administration or judicial management, with no pending insolvency applications. Must notify the Department within 5 working days of any material financial event during bid validity or contract term.

No explicit turnover threshold, bank guarantee, or bid bond amount is stated.

Mandatory registrations and status:

• Central Supplier Database (CSD) registration: CSD number (MAAA) must be provided for each bidding entity (single or each party in a JV/consortium).
• Tax compliance: Valid SARS Tax Compliance Status (TCS) PIN or printed TCS certificate. If no TCS PIN, CSD number must be provided. Each party in a JV/consortium must submit separately.
• VAT registration: Required (field on SBD 1).
• B-BBEE: Valid SANAS-accredited B-BBEE certificate or sworn affidavit (EME/QSE) to claim preference points. No minimum B-BBEE level is mandated for eligibility; points are claimed per the 90/10 table.
• GMP compliance: Declaration via PBD 5 confirming compliance with Medicines and Related Substances Act and no outstanding GMP/legal matters.
• Financial solvency: Declaration via PBD 11 confirming solvency and no insolvency proceedings.
• Compliance with Special Requirements and Conditions of Contract (SRCC) and General Conditions of Contract (GCC): Declaration via PBD 8.
• Independent bid determination: Covered in Bidder's Disclosure (SBD 4 equivalent).
• Declaration of interest: Covered in Bidder's Disclosure (state employment, relationships with procuring institution, other business interests).
• Authorised signatory: Board resolution or equivalent proof of authority (PBD 3 / PBD 3.1).
• Director/shareholder details: PBD 9.1 or PBD 9.2 as applicable.
• Supplier details: PBD 4.1 completed electronically.
• Third-party sourcing: If applicable, PBD 1, PBD 1.1 and third-party undertaking (PBD 1.2).
• NIP compliance: SBD 5 signed and submitted; post-award reporting to DTI if contract value exceeds R10 million.

Contract governed by Special Requirements and Conditions of Contract (SRCC) and General Conditions of Contract (GCC). Successful bidder must sign SBD 7 (Contract Form). NIP obligation agreement between DTI and successful bidder (does not involve the purchasing institution) if imported content threshold is met. NIP process: determine obligation, sign agreement, submit performance guarantee to DTI, submit business concept, submit detailed business plans, implement plans, submit bi-annual progress reports. Financial solvency declaration required (PBD 11) with 5-day notification of material financial events. GMP compliance declaration required (PBD 5) with undertaking to inform Department of any supply interruption. Compliance with SRCC and GCC declared via PBD 8. Bid validity 180 days.

Preference point system: 90/10 (Price 90, Specific Goals 10). Specific Goals are B-BBEE Status Level of Contributor with points: Level 1=10, Level 2=9, Level 3=8, Level 4=6, Level 5=5, Level 6=4, Level 7=3, Level 8=2, Non-compliant=0. Price points calculated using Ps = 90

• (1 - (Pt - Pmin) / Pmin). B-BBEE evidence: SANAS-accredited certificate or sworn affidavit (EME/QSE). Failure to submit evidence results in zero specific goal points but does not disqualify the bid. No minimum functionality threshold or additional evaluation stages are stated in the source text.